Blood in Urine While Taking Eliquis: Should You Stop?
Yes, you need to stop Eliquis immediately and contact your doctor or seek medical attention right away. Blood in the urine (hematuria) while taking Eliquis is a warning sign of bleeding that requires urgent evaluation and management 1.
Immediate Actions Required
Stop Eliquis now and get medical help. The 2020 ACC Expert Consensus guidelines provide clear direction: when you have clinically overt bleeding (which includes visible blood in urine), you should stop the oral anticoagulant 2. The FDA drug label for Eliquis explicitly lists "red, pink, or brown urine" as a sign requiring you to "call your doctor or get medical help right away" 1.
Why This Matters
Hematuria while on Eliquis indicates:
- Active bleeding that could worsen or signal underlying urological pathology
- Potential malignancy risk: Up to 24% of visible hematuria cases in anticoagulated patients are due to cancer 3
- Need for urgent evaluation: You require assessment for bleeding severity and underlying cause
What Happens Next: The Management Algorithm
Step 1: Assess Bleeding Severity
Your doctor will determine if this is a major bleed based on 2:
- Whether you have hemodynamic instability (low blood pressure, rapid heart rate, dizziness)
- If your hemoglobin dropped ≥2 g/dL or you need blood transfusions
- Amount and persistence of blood in urine
Step 2: Initial Management
For non-major hematuria (most common scenario):
- Stop Eliquis temporarily 2
- Provide local measures and supportive care
- Do NOT administer reversal agents for Eliquis in non-major bleeding 2
- Assess for contributing factors (other medications, kidney problems, uremia)
For major hematuria (severe, ongoing, or with instability):
- Stop Eliquis immediately 2
- Initiate bleeding control measures
- Consider reversal agents if life-threatening 2
- May require hospitalization and bladder irrigation
Step 3: Investigation
Do not delay diagnostic workup - you need evaluation for:
- Urological malignancy (present in 24-44% of anticoagulant-related hematuria cases) 4, 5
- Infection, stones, or other urinary tract pathology
- Kidney function assessment
When to Restart Eliquis
Restarting depends on several factors 2:
The guidelines recommend delaying restart if:
- You're at high risk of rebleeding
- The source of bleeding hasn't been identified yet
- You need surgical or invasive procedures
Restart can be considered once:
- Bleeding is controlled
- Underlying cause is identified and addressed
- Your doctor determines the thrombotic risk (stroke/clot risk) outweighs bleeding risk
Typically, if hematuria was mild and controlled, anticoagulation may resume within 48 hours to a few days 6, 3. However, your doctor must make this decision - never restart on your own.
Important Context About Eliquis and Hematuria
Research shows that:
- Anticoagulants like Eliquis increase hematuria risk significantly compared to no anticoagulation 4, 5
- Among anticoagulants, apixaban (Eliquis) is actually the safest regarding hematuria risk compared to warfarin, rivaroxaban, or dabigatran 7
- Most hematuria episodes on Eliquis are mild-to-moderate and resolve with temporary drug cessation 6
Critical Warnings
Do NOT simply continue Eliquis hoping the bleeding stops. The FDA label is explicit: visible blood in urine requires immediate medical contact 1.
Do NOT stop Eliquis long-term without medical guidance. If you're taking Eliquis for atrial fibrillation, stopping increases your stroke risk significantly 1. Your doctor may need to prescribe alternative anticoagulation or bridge therapy.
Seek emergency care immediately if you have:
- Large amounts of blood or blood clots in urine
- Inability to urinate
- Dizziness, weakness, or rapid heartbeat
- Severe abdominal or back pain
Bottom Line
Stop Eliquis now and contact your doctor immediately. Blood in the urine is not a side effect to "watch and wait" - it requires prompt evaluation to rule out serious causes and determine when safe anticoagulation can resume. Your doctor will balance your bleeding risk against your need for stroke/clot prevention and guide appropriate management.